XBiotech Inc (NASDAQ: XBIT) stock suffered a major decline of -10.2% on 9/3/24. The shares closed at $5.75. However, trading volume in this decline was exceptionally low at 49% of normal. Relative to the market […]
Notable negative changes in fundamentals have recently occurred for Universal Electronics Inc (NASDAQ: UEIC): significant quarterly sales deceleration occurred, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2024 decreased significantly. Universal Electronics […]
Perspective Therapeutics Inc (NYSEAMERICAN: CATX) stock closed at $14.18 on 9/3/24 after a major decline of -10.3%. NORMAL trading volume accompanied the decline. The stock has been exceptionally strong relative to the market over the […]
NovoCure Ltd (NASDAQ: NVCR) stock closed at $16.75 on 9/3/24 after a major decline of -13.8%. Moreover, exceptionally high trading volume at 204% of normal accompanied the decline. Relative to the market the stock has […]
KNOT Offshore Partners LP (NYSE: KNOP) has reported a loss for its second fiscal quarter (ending June 30) of $-0.43 versus a loss $-1.21 for the same period a year ago. This result fell short […]
Recent extremely important negative changes in fundamentals have impacted Hillenbrand Inc (NYSE: HI): the stock’s power rating fell below 50, significant quarterly earnings deceleration occurred, the consensus estimate for September, 2025 decreased significantly, and the […]
Comfort Systems USA Inc. (NYSE: FIX) stock closed at $314.82 on 9/3/24 after a major decline of -10.9%. NORMAL trading volume accompanied the decline. The stock has been exceptionally strong relative to the market over […]
On 9/3/24, Coeur Mining Inc (NYSE: CDE) stock suffered a major decline of -11.1%, closing at $5.46. Moreover, this decline was accompanied by above average trading volume at 120% of normal. Relative to the market […]
On 9/3/24, AudioEye Inc (NASDAQ: AEYE) stock suffered a major decline of -11.0%, closing at $21.55. Trading volume in this decline was normal. The stock has been exceptionally strong relative to the market over the […]
Atara Biotherapeutics Inc (NASDAQ: ATRA) stock suffered a major decline of -10.4% on 9/3/24. The shares closed at $6.81. Moreover, trading volume in this decline was exceptionally high at 383% of normal. The stock has […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research